Free-B-ring flavonoid and flavan mixture for dual COX-2 5-LO inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for conditions mediated by the COX-2 and 5-LO pathways, such as osteoarthritis and inflammatory diseases, often come with side effects like gastrointestinal damage and limited efficacy, and there is a need for dual inhibitors that can effectively target both pathways without these drawbacks.
Innovation Solution
A novel composition of Free-B-ring flavonoids and flavans, referred to as Univestin™, is developed, which is administered to simultaneously inhibit COX-2 and 5-LO enzymes, modulate mRNA production, and treat various diseases and conditions, including osteoarthritis, by adjusting the ratio of flavonoids to flavans in the composition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional COX-2 inhibitors are used to treat inflammatory diseases, then anti-inflammatory efficacy is improved, but gastrointestinal damage occurs
Solution Approach 1:
The patent combines two distinct compound classes (Free-B-ring flavonoids and flavans) into a single pharmaceutical composition that achieves dual inhibition of COX-2 and 5-LO pathways. This merging approach allows the composition to provide broad anti-inflammatory coverage while maintaining gastrointestinal safety, as neither compound class alone causes significant GI damage.
Solution Approach 2:
The invention uses a composite pharmaceutical formulation consisting of multiple natural compound classes (flavonoids and flavans) with complementary mechanisms of action. This composite approach enables simultaneous targeting of multiple inflammatory pathways (COX-2 and 5-LO) while leveraging the safety profiles of natural compounds to avoid gastrointestinal side effects associated with synthetic COX-2 inhibitors.
2Reliability
If dual COX-2 and 5-LO inhibitors are developed, then efficacy against multiple inflammatory pathways is improved, but drug complexity increases
Solution Approach 1:
The patent employs compounds with multi-functional properties that can inhibit multiple enzymatic pathways (both COX-2 and 5-LO) simultaneously. The Free-B-ring flavonoids and flavans exhibit broad-spectrum anti-inflammatory activity against multiple targets, allowing a single composition to address multiple inflammatory pathways without requiring complex multi-drug regimens.
Solution Approach 2:
The invention optimizes the ratio of Free-B-ring flavonoids to flavans in the composition to achieve effective dual inhibition. By adjusting these compositional parameters, the formulation achieves balanced inhibition of both COX-2 and 5-LO pathways while maintaining simplicity in administration and dosing.
3Device complexity
If single compound inhibitors are used, then drug simplicity is maintained, but ability to target multiple pathways is limited
Solution Approach 1:
The patent merges two complementary compound classes (Free-B-ring flavonoids and flavans) into a single pharmaceutical composition that can be administered as one unified treatment. This combination approach provides multi-pathway inhibition capability while maintaining dosing simplicity and avoiding the need for multiple separate medications.
Data Source
AI summary
The present invention provides a novel composition of matter comprised of a mixture of two specific classes of compounds—Free-B-ring flavonoids and flavans—for use in the prevention and treatment of diseases and conditions mediated by the COX-2 and 5-LO pathways. The present invention further provides a novel method for simultaneously inhibiting the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) enzymes, and reducing cox-2 mRNA production. Finally, the present invention includes a method for weight loss and blood glucose control. The methods of this invention are comprised of administering to a host in need thereof an effective amount of the composition of this invention together with a pharmaceutically acceptable carrier. This invention relates generally to the prevention and treatment of diseases and conditions mediated by the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) pathways, including but not limited to the relief joint discomfort and pain associated with conditions such as osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse.